peritoneal dissemination and appendiceal mucinous neoplasm
Conditions
Interventions
Hyperthermic intraperitoneal chemotherapy
Sponsors
Mie university gastrointestinal and pediatric surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ?Patients with peritoneal metastasis of gastric cancer,colon cancer, or appendicecal mucosal neoplasm ?Patients with positive peritoneal cytology ?Except for cases having distant metastasis such as liver and lung, and cases having non-healing factor such as unresectable lymph node metastasis except for peritoneal metastasis
Exclusion criteria
Exclusion criteria: ?Patients with heart disease(Arrhythmia requiring acute myocardial infarction within 6 months after the onset of ischemic heart disease, a medical treatment) ?Patients with a history of cerebrovascular disorder of cerebral infarction, cerebral hemorrhage, etc. ?Patients of systolic blood pressure less than 80mmHg or hypotension ?During pregnancy, Women suspected of being pregnant and Lactating woman ?Patients with dementia ?Patients with a history of shock during extracorporeal circulation therapy ?Patients taking stop angiotensin converting enzyme inhibitors, is difficult prior to extracorporeal circulation therapy ?Patients admitted unsuitable for the clinical study by research investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical factor(Blood loss, operative time, blood transfusion) ,and Perioperative factor(Complications, hospital stay, readmission rate after surgery) perioperative factor | — |
Countries
Japan
Contacts
Public ContactMasaki Ohi
Mie University Hospital Department of Innovative Surgery
Outcome results
None listed